Biomea Fusion, Inc. Common Stock BMEA
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-11T14:58:53.620Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T14:56:39.917117655Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-11T14:58:53.008590+00:00
Biomea Fusion, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | ||||||
| 45Δ | 1.03 | 787.3% | 60.8% | |||
| 50Δ | 1.11 | 749.9% | 52.1% | |||
| 55Δ | 1.19 | 712.4% | 43.4% | |||
| 60Δ | 1.27 | 674.9% | 34.8% | |||
| 65Δ | 1.35 | 637.4% | 26.1% | |||
| 70Δ | 1.43 | 599.9% | 17.4% | |||
| 75Δ | 1.51 | 562.9% | 9.1% | |||
| 80Δ | 1.74 | 533.1% | 7.1% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.03
- IV
- 787.3%
- B/E move
- 60.8%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.11
- IV
- 749.9%
- B/E move
- 52.1%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.19
- IV
- 712.4%
- B/E move
- 43.4%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.27
- IV
- 674.9%
- B/E move
- 34.8%
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.35
- IV
- 637.4%
- B/E move
- 26.1%
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.43
- IV
- 599.9%
- B/E move
- 17.4%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.51
- IV
- 562.9%
- B/E move
- 9.1%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.74
- IV
- 533.1%
- B/E move
- 7.1%
Options history
No recorded observations
Biotechnology
BMRN
BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San…
More →BNTC
Benitec Biopharma Inc., a developing biotechnology company, is focused on the development of new genetic drugs. The company is headquartered in Hayward, California.
More →BNTX
BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is headquartered in Mainz, Germany.
More →BYSI
BeyondSpring Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology cancer therapies. The company is headquartered…
More →CABA
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of T-cell therapies designed for patients with B-cell-mediated autoimmune…
More →CADL
Candel Therapeutics Inc. is a pioneering biotechnology company focused on revolutionizing cancer treatment through its proprietary oncolytic virus platform, which uniquely targets…
More →